RORγt agonist enhances tumor response to anti-PD-1 immunotherapy in cancers

This item is shared privately

figure

modified on 2021-09-22, 12:21

RORγt agonist enhances tumor response to anti-PD-1 immunotherapy in cancers

Categories

Biochemistry and cell biology not elsewhere classified

Keywords

Licence